Studies have shown that platelet APP ratio (representing the percentage of 120–130 kDa to 110 kDa isoforms of the amyloid precursor protein) is reduced in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) [33]. Here, APP is linked to Alzheimer disease.